Patent ID: 7884136

Claim:
A composition, comprising at least one pharmaceutically acceptable excipient; and two or more of the following crystalline compounds: (i) a crystalline compound of the formula: exhibiting an X-ray powder diffraction pattern with an X-ray source of Cu/30 kV and having characteristic peaks at about 6.70 °2Theta, about 12.51 °2Theta, about 19.60 °2Theta, about 22.93 °2Theta and about 26.11 °2Theta; (ii) a crystalline compound of the formula: exhibiting an X-ray powder diffraction pattern with an X-ray source of Cu/30 kV and having characteristic peaks at about 6.53 °2Theta, about 13.03 °2Theta, about 15.91 °2Theta, about 16.52 °2Theta and about 23.11 °2Theta; and (iii) a crystalline compound of the formula: exhibiting an X-ray powder diffraction pattern with an X-ray source of Cu/30 kV and having characteristic peaks at about 8.06 °2Theta, about 12.28 °2Theta, about 16.00 °2Theta, about 18.07 °2Theta and about 25.12 °2Theta.